Is Second Sight Closing up Shop?
Second Sight Medical Products is the latest medtech company to face tough losses as a result of the financial impact of the novel coronavirus (SARS-CoV-2). The Sylmar, CA-based company is laying off 84 of its 108 employees and said it intends to wind-down operations. The firm develops implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals. FDA greenlit the Argus II retinal prosthesis system in 2013. Plans now call for the Second Sight to retain an adviser experienced in winding down operations to guide the board on the next steps. Any wind down activity, if implemented, will be subject to uncertainties. Second Sight said additional layoffs are expected to be made at a later date based on its level of operations. The company is now working on the Orion Visual Cortical Prosthesis System (Orion). It is an implanted cortical stimulation device intended to provide useful artificial vision to individuals who are blind due to a wide range of causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. This is a departure from the companyâs previous success. In 2013, MD+DI named Second Sight Manufacturer of the Year. The firm was launched in 1998. The measure follows weight-loss specialist Obalon Therapeutics announcing it explored financial and strategic alternatives because of the impact of COVID-19 on elective procedures. Â
Publication date: Available online 25 May 2020Source: Journal of the American College of RadiologyAuthor(s): Sherry S. Wang, Marilyn A. Roubidoux
Publication date: Available online 25 May 2020Source: Academic RadiologyAuthor(s): Amel Amalou, Baris Turkbey, Sheng Xu, Evrim Turkbey, Peng An, Gianpaolo Carrafiello, Anna Maria Ierardi, Robert Suh, Hayet Amalou, Bradford J. Wood
Authors: Tung-Chen Y PMID: 32446685 [PubMed - as supplied by publisher]
Authors: Pérez-Suárez B, Martínez-Menchón T, Cutillas-Marco E PMID: 32446684 [PubMed - as supplied by publisher]
Authors: López Castro J PMID: 32446683 [PubMed - as supplied by publisher]
CONCLUSIONS: The average patient is middle aged (often male) with a history of subacute back pain, sometimes presenting fever and/or neurological damage on diagnosis. Acute phase reactants are frequently raised. Diabetes mellitus, endocarditis and immunosuppressed patients may have the worst chance of a good outcome, therefore these patients should be more carefully managed (always try to obtain an imaging-guided biopsy, correct antibiotic treatment, and a functional and clinical follow-up). PMID: 32446680 [PubMed - as supplied by publisher]
AbstractSARS-CoV2 is dramatically impacting the global population. Worldwide, pharmacists are changing their roles and being increasingly recognized for their role as essential service providers. This commentary provides some examples collected from Asia, Europe, the Americas and Africa, ranging from essential services to meet human rights basic needs, extended generalist services developed to ensure continuity of care and supply of essential medicines to the development of differentiated extended responsibilities in emergency care. All examples were collected using a network of pharmacists from 27 countries, representing ...
A light bulb went off when I saw a bumper sticker for sale that read “Always remember you’re unique, just like everyone else.” Yes, we are special. But are we more special than others? Many people flash a wry smile as they read my head-turning — if not head-scratching — bumper sticker. Attachment theory tells us that children need to feel welcomed, wanted, and loved. They need to feel special in the eyes of caregivers in order to develop a secure internal based. Even as adults, we want to feel special to our partner and close friends. But can our desire to be special become a liability? It&rs...
Publication date: Available online 24 May 2020Source: Journal of Minimally Invasive GynecologyAuthor(s):
Psychologists say anxiety and uncertainty prompt irrational decisions — like turning down a transplant when an organ becomes available.